Over 10,000 filings
Page 11 of 100
8-K
vgoxa sd02bs
20 Sep 24
Entry into a Material Definitive Agreement
8:35am
6-K
rsxpm6
20 Sep 24
Report of Foreign Private Issuer
8:35am
8-K
po9 qq1aal
20 Sep 24
ChromaDex Appoints Ozan Pamir as Chief Financial Officer
8:32am
8-K
wli 36cjr1p6bnhgghm
20 Sep 24
Other Events
8:31am
8-K
g48 2tshihizdp2gzp
20 Sep 24
EnerSys Selected for $199 Million Award Negotiation to Develop State-of-the-Art Lithium-Ion Cell Gigafactory
8:31am
6-K
bfr6o8bv80szujcojxk
20 Sep 24
Current report (foreign)
8:30am
8-K
ctfd9
20 Sep 24
Unaudited Pro Forma Condensed Consolidated Financial Statements
8:28am
8-K
w8x 5j8b57
20 Sep 24
Regulation FD Disclosure
8:23am
8-K
ipmg00q8scqch
20 Sep 24
TransDigm Group Declares a Special Cash Dividend of $75.00 Per Share and Announces Successful Completion of Incremental Debt
8:22am
8-K
gs630m1wi0p i4gqvo
20 Sep 24
Marinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst Day
8:15am
8-K
cepkceo39kt3
20 Sep 24
Dr. Carlo Papa Appointed to Board of Directors of Odysight.ai
8:10am
8-K
tpj4rg p2gsz7
20 Sep 24
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
8:08am
8-K
h8we4765d7hpkqj3tgy
20 Sep 24
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
8:05am
8-K/A
nxwsqdmqwmxtpacf
20 Sep 24
Regulation FD Disclosure
8:05am
8-K
hx8hlk l4ff3wf
20 Sep 24
MicroStrategy Completes $1.01 Billion Offering of 0.625% Convertible Senior Notes Due 2028
8:04am
6-K
wtc0knofscry
20 Sep 24
Report of Foreign Private Issuer
8:03am
6-K
l1q4hby991mf7xcm5k
20 Sep 24
Current report (foreign)
8:01am
8-K
4fzfx4yvcut5iwb9gihb
20 Sep 24
Amendments to Articles of Incorporation or Bylaws
8:00am
6-K
vw82cttmpvh
20 Sep 24
Current report (foreign)
8:00am
6-K
0nma1n3gyvzf1t
20 Sep 24
Report of Foreign Private Issuer
8:00am